The Role of Evidence in the US Response to the Opioid Crisis

Abstract The National Institutes of Health is investing hundreds of millions of dollars into new research on opioids. As these studies yield insights and results, their results will have to change policy and practice before they can bend the curve of the epidemic. However, the United States does not...

Full description

Saved in:
Bibliographic Details
Published in:Epidemiologic reviews 2020-01, Vol.42 (1), p.167-170
Main Authors: Sharfstein, Joshua M, Olsen, Yngvild
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract The National Institutes of Health is investing hundreds of millions of dollars into new research on opioids. As these studies yield insights and results, their results will have to change policy and practice before they can bend the curve of the epidemic. However, the United States does not have a strong track record of translating evidence on drug policy into action. Three reasons for the translation gap are the historical legacy of drugs in the United States, vested interests, and politics. Researchers can become engaged in policy and political processes to strengthen the US response.
ISSN:1478-6729
1478-6729
DOI:10.1093/epirev/mxaa004